The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by McClusky, H. Y.
* Articles by Wooten, V.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by McClusky, H. Y.
* Articles by Wooten, V.

Am J Psychiatry 1991; 148:121-126
Copyright © 1991 by American Psychiatric Association


BRIEF REPORTS

Efficacy of behavioral versus triazolam treatment in persistent sleep- onset insomnia

HY McClusky, JB Milby, PK Switzer, V Williams and V Wooten
Department of Psychology, University of Alabama, Birmingham.

OBJECTIVE: This study compared differential effects of behavioral therapy and triazolam in a clinical population with sleep-onset insomnia. Triazolam was hypothesized to decrease sleep latency and frequency and duration of awakening, with some effects during the first night's administration. But at follow-up, sleep measures were predicted to return to baseline levels. Behavioral treatment was hypothesized to effect sleep after 2 or more weeks of training which persisted at follow-up. METHOD: Thirty patients with average sleep latencies of 81.48 minutes, who reported chronic insomnia for an average of 2.6 years, were randomly assigned to one of two treatment groups: behavioral stimulus control/relaxation training and triazolam. RESULTS: Both treatments decreased sleep latency but differentially. Triazolam was effective immediately but maintained only some gains at follow-up. Behavioral treatment decreased sleep latency beginning the second week, when subjects expected no improvement, with gains maintained at follow- up. Comparisons showed that triazolam group latencies returned toward baseline, while behavioral group gains were maintained at follow-up. CONCLUSIONS: Triazolam treatment showed superior immediate treatment effects, while behavioral treatment showed superior treatment effects at follow-up, effects that accrued during the training period and differentially persisted at follow-up. One treatment strategy implied by these results would be to combine these two interventions concurrently. This would seem to use the immediate effects produced by the medication until the behavioral skills were learned, at which point medication would be terminated. This strategy could offer immediate relief and sustained effects at drug termination.


This article has been cited by other articles:


Home page
AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
A. M. Lynch, C. I. Jarvis, R. J. DeBellis, and A. K. Morin
State of the Art Reviews: Nonpharmacologic Approaches for the Treatment of Insomnia
American Journal of Lifestyle Medicine, August 1, 2007; 1(4): 274 - 282.
[Abstract] [PDF]


Home page
JCOHome page
J. Savard, S. Simard, H. Ivers, and C. M. Morin
Randomized Study on the Efficacy of Cognitive-Behavioral Therapy for Insomnia Secondary to Breast Cancer, Part I: Sleep and Psychological Effects
J. Clin. Oncol., September 1, 2005; 23(25): 6083 - 6096.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. H. Silber
Chronic Insomnia
N. Engl. J. Med., August 25, 2005; 353(8): 803 - 810.
[Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
R. M. Benca
Diagnosis and Treatment of Chronic Insomnia: A Review
Psychiatr Serv, March 1, 2005; 56(3): 332 - 343.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. T. Smith, M. L. Perlis, A. Park, M. S. Smith, J. Pennington, D. E. Giles, and D. J. Buysse
Comparative Meta-Analysis of Pharmacotherapy and Behavior Therapy for Persistent Insomnia
Am J Psychiatry, January 1, 2002; 159(1): 5 - 11.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Ment. HealthHome page
T. Furukawa
Review: benzodiazepines increase sleep duration but also lead to adverse effects in adults with insomnia
Evid. Based Ment. Health, August 1, 2000; 3(3): 81 - 81.
[Full Text]


Home page
CMAJHome page
A. M. Holbrook, R. Crowther, A. Lotter, C. Cheng, and D. King
Meta-analysis of benzodiazepine use in the treatment of insomnia
Can. Med. Assoc. J., January 1, 2000; 162(2): 225 - 233.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. M. Morin, C. Colecchi, J. Stone, R. Sood, and D. Brink
Behavioral and Pharmacological Therapies for Late-Life Insomnia: A Randomized Controlled Trial
JAMA, March 17, 1999; 281(11): 991 - 999.
[Abstract] [Full Text] [PDF]


Home page
Journal of Applied GerontologyHome page
N. Hall
Taking Policy Action to Reduce Benzodiazepine Use and Promote Self-Care Among Seniors
Journal of Applied Gerontology, September 1, 1998; 17(3): 318 - 351.
[Abstract] [PDF]


Home page
Behav ModifHome page
B. W. Riedel, K. L. Lichstein, B. A. Peterson, M. T. Epperson, M. K. Means, and R. N. Aguillard
A Comparison of the Efficacy of Stimulus Control for Medicated and Nonmedicated Insomniacs
Behav Modif, January 1, 1998; 22(1): 3 - 28.
[Abstract]




Get information about faster international access.

Privacy Policy

Copyright © 1991 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org